Records containing: NAFLD
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-08-31Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
-
CLINICAL_TRIALS study record update · 2026-04-20Influence of a Different Percentage of Nutrients on the Effects of a Low-calorie Mediterranean Diet Associated With Physical Exercise on the Parameters of Steatosis, Intestinal Function and Metabolic Risk in Patients With Obesity and NAFLD
-
CLINICAL_TRIALS study record update · 2026-04-17Prospective Cohort Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
-
CLINICAL_TRIALS study record update · 2026-04-16Evaluation of the Effects of Tomato Consumption on the Parameters of Hepatic Steatosis, Intestinal Function and on Glucose and Lipid Metabolism in Subjects With NAFLD
-
CLINICAL_TRIALS study record update · 2026-04-15Pilot Trial of Bicalutamide Versus Placebo in Reproductive-Aged Women With Nonalcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovary Syndrome (PCOS)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-15Dasatinib and Quercetin, a Combination of Senolytics to Treat Fibrotic Non-alcoholic Fatty Liver Disease - the TRUTH Study
-
CLINICAL_TRIALS study record update · 2026-04-13Androgens and Nonalcoholic Fatty Liver Disease (NAFLD) In Reproductive-Aged Women With and Without Polycystic Ovary Syndrome (PCOS)
-
CLINICAL_TRIALS study record update · 2026-04-09PRObiotic Mixed With Exercise THErapy USe in MAFLD (PROMETHEUS in MAFLD)
-
CLINICAL_TRIALS study record update · 2026-04-09Accurate Point of Care Liver Disease Diagnostics
-
CLINICAL_TRIALS study record update · 2026-04-08A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Treatment With DD01 for 48 Weeks in Overweight/Obese Subjects With MASLD/MASH
-
CLINICAL_TRIALS study record update · 2026-04-06The GLP-1 Agonist Semaglutide for the Treatment of Metabolic Disease in Liver Transplant Recipients: A Phase IV, Randomized Trial
-
CLINICAL_TRIALS study record update · 2026-03-27Targeting the Epigenetic Regulators Suv420h1/2 in Hepatocytes to Treat Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-27Effects of Two Different Exercise Programs Combined With the Mediterranean Diet on Inflammatory Status in Subjects With Obesity and NAFLD
-
CLINICAL_TRIALS study record update · 2026-03-27Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-11Feasibility Study for Quantifying Fatty Liver Using Thermo-acoustic Imaging
-
CLINICAL_TRIALS study record update · 2026-03-10Effect of Very Low-calorie Diet on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and Non-alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-10Effect of Glucagon-like Peptide -1 Receptor Agonist on Liver Tissue and Plasma Lipids in MASLD
-
CLINICAL_TRIALS study record update · 2026-03-10Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
-
CLINICAL_TRIALS study record update · 2026-03-06Study of Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-03-05The Effects of Glucagon on Hepatic Metabolism
-
CLINICAL_TRIALS study record update · 2026-03-02Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Adults With Compensated Cirrhosis Secondary to Metabolic Dysfunction-Associated Steatohepatitis
-
CLINICAL_TRIALS study record update · 2026-01-30Effects of Empagliflozin on Preventing Fibrosis and Cirrhosis Progression in Nucleos(t)Ide Analogue-treated Chronic Hepatitis B Patients With F2-F4 Fibrosis: a Randomized, Double-blind Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-23Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
-
CLINICAL_TRIALS study record update · 2026-01-20SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2026-01-15Nonalcoholic Fatty Liver Disease In Persons Living With HIV Database Study